QR-koodi

Activity and Diffusion of Tigecycline (GAR-936) in Experimental Enterococcal Endocarditis

The activity of tigecycline (GAR-936), a novel glycylcycline, was investigated in vitro and in experimental endocarditis due to the susceptible Enterococcus faecalis JH2-2 strain, its VanA type transconjugant BM4316, and a clinical VanA type strain, E. faecium HB217 resistant to tetracycline. MICs o...

Täydet tiedot

Tallennettuna:
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Lefort, Agnès, Lafaurie, Matthieu, Massias, Laurent, Petegnief, Yolande, Saleh-Mghir, Azzam, Muller-Serieys, Claudette, Le Guludec, Dominique, Fantin, Bruno
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology (ASM) 2003
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC148965/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12499194/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.1.216-222.2003
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia